Von Willebrand Disease (VWD) is a bleeding disorder where blood doesn't clot properly. This study looks at bleeding events and treatments in people with VWD to gather important information. The study is for people with Type 1 VWD, but others with Type 2 or 3 may join with special approval. **Key Points:** - The study lasts about 4 months, but you can choose to stay for up to 12 months. - Participants will have check-ins every two weeks via telemedicine. - You must be 16 or older, have a history of bleeding, and meet certain health criteria to join. You cannot participate if you have a history of certain blood clots, are pregnant, or have other bleeding disorders. If you have taken experimental treatments recently, you might not be eligible. This study will help create better treatments for VWD in the future.